Inventor · disambiguated record
Shridhar Bhat
Also filed as: BHAT SHRIDHAR
8 granted patents·3 pending applications·71 citations·filing 2008–2021
85Inventor score
Top patents by PatentIndex Score
11 records- 0193US9250237B2Hybrid cyclic libraries and screens thereofLIU JUN O·Filed 2011·Granted Feb 2, 2016·39 cites·28 claims
- 0286US9783577B2Hybrid cyclic libraries and screens thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Oct 10, 2017·5 cites·11 claims
- 0386US8729097B2Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and SIRT1, and methods of treating disordersLIU JUN O·Filed 2009·Granted May 20, 2014·19 cites·22 claims
- 0484US9095589B2Chirally pure isomers of itraconazole for use as angiogenesis inhibitorsLIU JUN O·Filed 2012·Granted Aug 4, 2015·5 cites·9 claims
- 0583US10414801B2Hybrid cyclic libraries and screens thereofUNIV JOHNS HOPKINS·Filed 2017·Granted Sep 17, 2019·3 cites·11 claims
- 0676US12049521B2Hybrid cyclic libraries and screens thereofUNIV JOHNS HOPKINS·Filed 2021·Granted Jul 30, 2024·0 cites·10 claims
- 0776US10954273B2Hybrid cyclic libraries and screens thereofUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 23, 2021·0 cites·8 claims
- 0851US2009198050A1Macrocyclic Modulators of the Ghrelin ReceptorTRANZYME PHARMA INC·Filed 2008·Application pending·0 cites
- 0949US2011124649A1Inhibitors of human methionine aminopeptidase 1 and methods of treating disordersUNIV JOHNS HOPKINS·Filed 2008·Application pending·0 cites
- 1047US2011262517A1Chirally pure isomers of itraconazole and inhibitors of lanosterol 14a-demethylase for use as angiogenesis inhibitorsUNIV JOHNS HOPKINS·Filed 2008·Application pending·0 cites
- 1131US10472315B2Inhibitors of methionine aminopeptidases and methods of treating disordersLIU JUN O·Filed 2010·Granted Nov 12, 2019·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Shridhar Bhat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →